These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Salvage high-dose chemotherapy with allogeneic stem-cell support for relapse or incomplete remission following high-dose chemotherapy with autologous stem-cell transplantation for hematologic malignancies. Tecnologica MAP Suppl; 2000 Jun; ():16-9. PubMed ID: 11067684 [No Abstract] [Full Text] [Related]
3. Salvage high-dose chemotherapy with allogeneic stem-cell support for relapse following high dose chemotherapy with autologous stem-cell support for solid tumors. Tecnologica MAP Suppl; 1999 Jun; ():16-7. PubMed ID: 10848040 [No Abstract] [Full Text] [Related]
4. High dose lymphoablative therapy (HDLT) with or without stem cell rescue for treatment of severe autoimmune diseases. Tecnologica MAP Suppl; 2000 Apr; ():10-2. PubMed ID: 11010674 [No Abstract] [Full Text] [Related]
5. High-dose chemotherapy with autologous stem-cell support for epithelial ovarian cancer. Tecnologica MAP Suppl; 1998 Feb; ():15-7. PubMed ID: 10183353 [No Abstract] [Full Text] [Related]
6. FDG PET for evaluating breast cancer. Tecnologica MAP Suppl; 2001 Apr; ():7-13. PubMed ID: 11718146 [No Abstract] [Full Text] [Related]
7. High-dose chemotherapy with autologous stem-cell support for epithelial ovarian cancer. Tecnologica MAP Suppl; 1999 Jan; ():5-7. PubMed ID: 10346739 [No Abstract] [Full Text] [Related]
8. High-dose chemotherapy with autologous stem-cell support in the treatment of high-risk, primary breast cancer. Tecnologica MAP Suppl; 1999 Jan; ():8-10. PubMed ID: 10346740 [No Abstract] [Full Text] [Related]
9. "Tandem" high-dose chemoradiotherapy with autologous stem-cell support in the treatment of newly diagnosed or responsive multiple myeloma. Tecnologica MAP Suppl; 1998 Feb; ():32-4. PubMed ID: 10183358 [No Abstract] [Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
17. Placental and umbilical cord blood as a source of stem cells for hematopoietic support (Executive summary file). Tecnologica; 1996 Oct; ():7-10. PubMed ID: 10179815 [No Abstract] [Full Text] [Related]